Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
Non-small cell lung cancer (NSCLC) remains the most prevalent and one of the deadliest cancers worldwide. Despite recent success, there is still an urgent need for new therapeutic strategies. It is also becoming increasingly evident that combinatorial approaches are more effective than single modali...
Saved in:
Main Authors: | Ilaria Guerriero (Author), Gianni Monaco (Author), Vincenzo Coppola (Author), Arturo Orlacchio (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum and glucocorticoid-regulated kinase 1 (SGK1) as an emerging therapeutic target for cardiac diseases
by: Fatemeh Yarmohammadi, et al.
Published: (2024) -
Common Variants in Serum/Glucocorticoid Regulated Kinase 1 (SGK1) and Blood Pressure Responses to Dietary Sodium or Potassium Interventions: A family-Based Association Study
by: Chao Chu, et al.
Published: (2015) -
Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors
by: Hyunsoo Jang, et al.
Published: (2022) -
Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention
by: Rajesh Basnet, et al.
Published: (2018) -
Expression Profiles of GILZ and SGK-1 in Potentially Malignant and Malignant Human Oral Lesions
by: Mahmood S. Mozaffari, et al.
Published: (2021)